Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing an US-MRI Biomarker Fusion Model for Endometriosis (DEFEND)

NCT04974710 is registered in ClinicalTrials.gov with Perspectum as lead sponsor.

NCT NCT04974710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04974710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing an US-MRI Biomarker Fusion Model for Endometriosis (DEFEND)
Lead sponsor
Perspectum
Phase
Observational
Overall status
Completed
Start date
March 18, 2022
Completion date
March 31, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis, reproductive system disorder